Suchergebnisse - "Ader, Florence"

PubPharm (256)

41

Final results of the DisCoVeRy trial of remdesivir for patients admitted to hospital with COVID-19

enthalten in: The Lancet. Infectious diseases | 2022

von Ader, F. | Bouscambert-Duchamp, M. | Hites, M. | +104

42

Remdesivir and three other drugs for hospitalised patients with COVID-19 : final results of the WHO Solidarity randomised trial and updated meta-analyses

enthalten in: Lancet (London, England) | 2022

von WHO Solidarity Trial Consortium | Pan, H. | Peto, R. | +98

CommentIn: Lancet. 2022 May 21;399(10339):1918-1920. - PMID 35512729

43

Prise en charge médicale du Covid-19, hors réanimation

enthalten in: La Revue du praticien | 2022

von Javaux, C. | Ader, F.

44

A retrospective comparison of COVID-19 and seasonal influenza mortality and outcomes in the ICUs of a French university hospital

enthalten in: European journal of anaesthesiology | 2022

von de Marignan, D. | Vacheron, C. | Ader, F. | +15

45

Effect of remdesivir on viral dynamics in COVID-19 hospitalized patients : a modelling analysis of the randomized, controlled, open-label DisCoVeRy trial

enthalten in: The Journal of antimicrobial chemotherapy | 2022

von Lingas, G. | Néant, N. | Gaymard, A. | +17

46

Outcome of Progressive Multifocal Leukoencephalopathy Treated by Interleukin-7

enthalten in: Annals of neurology | 2022

von Lajaunie, R. | Mainardi, I. | Gasnault, J. | +48

47

Remdesivir for the treatment of hospitalised patients with COVID-19: final results from the DisCoVeRy randomised, controlled, open-label trial

enthalten in: bioRxiv.org | 2022

von Ader, F. | Bouscambert-Duchamp, M. | Hites, M. | +70

48

Immune response to three doses of mRNA SARS-CoV-2 vaccines in CD19-targeted chimeric antigen receptor T cell immunotherapy recipients

enthalten in: Cancer cell | 2022

von Sesques, P. | Bachy, E. | Ferrant, E. | +5

49

Fatal Community-Acquired Peritonitis Due to Invasive Necrotizing Intestinal Mucormycosis : Case Report and Review of the Literature

enthalten in: Turkish journal of anaesthesiology and reanimation | 2022

von Vassal, O. | Dupont, D. | Ader, F. | +5

50

An open-label randomized, controlled trial of the effect of lopinavir/ritonavir, lopinavir/ritonavir plus IFN-β-1a and hydroxychloroquine in hospitalized patients with COVID-19 – Final results from the DisCoVeRy trial

enthalten in: bioRxiv.org | 2022

von Ader, F. | Peiffer-Smadja, N. | Poissy, J. | +55